Skip to content
Search

Latest Stories

More at risk of type 2 diabetes after gaining weight during lockdown: NHS study

People having put weight during the lockdowns are at higher risk of developing type 2 diabetes and those seeking weight-loss help has also seen a rise than before the start of the coronavirus pandemic, a new NHS study has found.

According to the research, people asking for weight-loss help are on average 2.27kg (5lbs) heavier than those starting the programme during the previous three years.


The study, published in Lancet, reveals that people aged under 40 who have enrolled on the NHS diabetes prevention programme have put on the most weight and are, on average, 8lbs heavier than those enrolled before the pandemic.

An increase in weight by 1kg could increase the risk of developing diabetes by about 8 per cent. The study added that at the present rate the growing number of diabetics could result in nearly 39,000 extra people suffering a heart attack in 2035, and more than 50,000 experiencing a stroke.

Prof Jonathan Valabhji, NHS national clinical director for diabetes and obesity who produced the findings, said people concerned about weight gain should get help as soon as possible.

“The pandemic has changed every part of our lives and taken a toll on mind and body, with thousands of people paying a heavy price, and many gaining weight during lockdown,” he said.

“The increase in weight also means an increased risk of type 2 diabetes – which is associated with many of the common types of cancer, blindness, amputations as well as heart attacks and strokes.”

He urged people to consider the NHS diabetes prevention programme, adding that NHS data showed that people completing the programme typically achieved an average weight loss of 3.3kg, and 3.6kg for those who are overweight or obese, reducing their risk of type 2 diabetes.

Moreover, the NHS has fast-tracked access to the programme after research found that people are twice as likely to die from Covid-19 if they have type 2 diabetes. The NHS is also promoting online tools to help diabetics manage their condition safely.

Diabetes UK is hosting a self-assessment tool, which helps people calculate their risk of developing type 2 diabetes by answering questions about risk factors including age, weight and ethnicity.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less